Intellectual Disability (ID)

Definition

Significant limitations in both intellectual functioning (reasoning, learning, problem-solving) and adaptive behavior (conceptual, social, and practical skills), with onset before age 18.

1. Deficits in intellectual functioning confirmed by clinical evaluation and standardized IQ testing
2. Deficits in adaptive functioning that cause failure to meet developmental and social standards in one or more domains of daily living
3. Onset during the developmental period (before age 18)

Epidemiology

• Prevalence: approximately 1% of the general population when defined using both intellectual and adaptive criteria; rises to ~3% if IQ <75 is used alone
• Global developmental delay (GDD) affects 1-3% of children under 5 years; the ID label is not applied before age 5 since IQ testing is unreliable in that age group
• Sex ratio: boys:girls = 1.4:1, more pronounced in mild ID; ~15% of males with ID have X-linked ID (XLID); about 25% of males with severe ID have XLID
• Mild ID accounts for ~85% of all cases; moderate ~10%; severe ~4%; profound ~1-2%
• Recurrence risk in families with one child with severe ID: 3-9% - Bradley and Daroff's Neurology, p. 1895

Severity Classification

Etiology

• Chromosomal: Down syndrome (trisomy 21), fragile X syndrome, Prader-Willi/Angelman syndromes, Williams syndrome (del 7q11), velocardiofacial syndrome (del 22q11)
• Metabolic/genetic: PKU, galactosemia, Lesch-Nyhan syndrome, Hurler syndrome, Hunter syndrome
• Intrauterine infections: TORCH (toxoplasma, rubella, CMV, herpes)
• Teratogens: fetal alcohol syndrome, prenatal drug exposure, lead intoxication

• Birth asphyxia/hypoxic-ischemic encephalopathy
• Prematurity, very low birth weight
• Neonatal hypoglycemia, hyperbilirubinemia

• CNS infections (meningitis, encephalitis)
• Head trauma
• Hypothyroidism (if untreated)
• Social deprivation/severe neglect (partially reversible)

Genetic Syndromes - Cognitive/Behavioral Profiles

• Bradley and Daroff's Neurology, p. 1896

Diagnosis

Intellectual Functioning

• Wechsler Scales (WISC, WAIS) and Stanford-Binet are most commonly used
• Cutoff: IQ approximately 70 (2 SD below mean of 100, SD=15), with a ±5-point margin
• IQ alone is insufficient; adaptive function must also be impaired

Adaptive Functioning

• Vineland Adaptive Behavior Scale-II (VABS-2) is the most widely used standardized measure
• Assesses: communication, daily living skills, socialization, motor skills
• Produces an Adaptive Behavior Composite score

Workup

• Chromosomal/genetic: karyotype, chromosomal microarray, targeted gene panels
• Metabolic: blood/urine amino acids and organic acids (for PKU, galactosemia, Hurler/Hunter, Lesch-Nyhan)
• Neuroimaging: MRI preferred - high rates of abnormality in microcephaly, cerebral palsy, severe/profound ID
• EEG: if seizures are suspected (nonspecific slowing is common in ID populations)
• Hearing/speech evaluation: routine - hearing impairment can mimic ID
• Prenatal (retrospective or for future pregnancies): amniocentesis, chorionic villus sampling, cfDNA (MaterniT21 for trisomies)

Differential Diagnosis

• Sensory impairment (deafness, blindness) mimicking ID if undetected
• Speech/language disorders (expressive/receptive)
• Cerebral palsy (motor impairment without necessarily cognitive impairment)
• Specific learning disorders (delay in one domain, not global)
• Severe neglect/deprivation (partially reversible)
• Uncontrolled seizure disorders causing secondary cognitive decline
• Dementia (onset after age 18)

ID vs. Autism Spectrum Disorder

• 70-75% of individuals with ASD have IQ <70; approximately 19.8% of those with ID also have ASD
• ASD shows disproportionately more severe impairment in social relatedness and language relative to the overall level of ID - Kaplan and Sadock's Synopsis of Psychiatry, p. 335

Comorbidities

• Epilepsy: up to 1 in 5 children with ID develop epilepsy by age 10; 5x higher risk with severe vs. mild ID (35% vs. 7%)
• ADHD: significantly higher rates than in the general population
• Anxiety disorders, depressive disorders
• Autism spectrum disorder (as above)
• Cerebral palsy
• Psychiatric comorbidity (2025 systematic review, PMID 40705563): confirms high rates of multiple psychiatric conditions in individuals with intellectual developmental disorders

Course and Prognosis

Treatment and Management

Prevention

• Primary: PKU newborn screening + low-phenylalanine diet; abstinence from alcohol in pregnancy; genetic counseling; prenatal diagnosis
• Secondary: early detection and treatment of metabolic/endocrine disorders (e.g., hypothyroidism)
• Tertiary: minimizing disability through early intervention

Psychosocial Interventions

• Educational: comprehensive programs addressing academics, adaptive skills, social skills, vocational training in the least restrictive environment (mandated by IDEA in the US)
• Behavioral therapy: positive reinforcement, behavior modification for aggression, self-injurious behavior
• Cognitive-behavioral therapy (CBT): modified for cognitive level; relaxation, self-instruction, dispelling false beliefs
• Family education: parent training in management strategies, advocacy support

Pharmacological

• ADHD: methylphenidate, dextroamphetamine, clonidine, guanfacine
• Aggression/impulsivity: risperidone (FDA-approved), aripiprazole, mood stabilizers (valproate, carbamazepine), propranolol
• Anxiety/OCD: SSRIs (fluoxetine, sertraline, fluvoxamine)
• Seizures: valproate, lamotrigine, oxcarbazepine, carbamazepine, topiramate
• Self-injurious behavior: naloxone, propranolol, fluoxetine

Support Resources

• The Arc (thearc.org)
• Parent Center Hub (parentcenterhub.org)
• American Association on Intellectual and Developmental Disabilities (AAIDD)